InsidersTradesSigma
Follow the Anthem Biosciences Limited stock price and the full insider trade history of the company, a publicly traded company based in India. Shares trade on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Anthem Biosciences Limited has recorded 3 reports. Market capitalisation: €443.8bn. The latest transaction was disclosed on 11 March 2026 (Sale). Among the most active insiders: Viridity Tone LLP. The full history is free.
Analysts rate Anthem Biosciences Limited Strong Buy (bullish), based on 7 analysts. Average price target: ₹884.43.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
Anthem Biosciences Limited 是一家健康和制药领域的公司，提供生物技术和研究服务。该公司在孟买证券交易所（XBOM）上市。